wendell wierenga sri board of directors  sri international skip to main content toggle menu sectorsbiosciences health and medical systems chemistry materials and energy computing and information technology defense and security education and learning ocean and space robotics sensors and devices custom solutions services  solutionsrd innovation consulting technology solutions bioscience contract research specialized services specialized facilities venturestechnology for license portfolio clients  partnerssupplier relations aboutour organization our team timeline of innovation alumni newsroom publications blog careers contact  search form search homeabout usour peoplewendell wierenga wendell wierenga independent consultantwendell wierenga phd joined sri’s board of directors in  previously he was executive vice president of research and development rd of santarus inc from  to  executive vice president of rd at ambit biosciences from  and executive vice president at neurocrine biosciences which he joined in   from  to  wierenga was chief executive officer of syrrx inc a private biotech company specializing in highthroughput structurebased drug design sold to takeda in  prior to joining syrrx from  to  he was senior vice president of worldwide pharmaceutical sciences technologies and development at parkedaviswarner lambert now pfizer from  wierenga was senior vice president of drug discovery and preclinical development at parke davis concurrent with his tenure there he was vice president of medtech ventures a warner lambert investment fund  prior to parkedavis wierenga was at upjohn pharmaceuticals for  years where his last position was executive director of discovery research wierenga led andor participated in the rd of more than  investigational new drug ind disclosures more than  new drug applications ndas and  marketed products including lipitor® neurontin® lyrica® and uceris®  wierenga serves on the following public company boards cytokinetics inc apricus biosiences inc concert pharmaceuticals and ocera therapeutics inc and three private company boards patara pharma crinetics and dermata therapeutics he also serves on the scientific advisory boards of ferring research institute and atyr pharma and he is an ongoing advisor to hovione lisbon portugal and the life sciences institute university of michigan   he earned his phd in chemistry from stanford university unavailable  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries this feature is temporarily unavailable copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  cytk stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventscytk cytokinetics inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all briefcytokinetics reports baseline data from first cohort of phase  clinical trial of ck in patients with sma reuters –  am et  cytokinetics inc cytk  cytokinetics cytk announces baseline data from first cohort of phase  clinical trial of ck in patients with sma  cytokinetics cytk screen failures in cohort  primarily due to hfmse score that was either too high in ambulatory patients or too low in nonambulatory patients cytokinetics announces baseline data from first cohort of phase  clinical trial of ck in patients with sma globenewswire –  am et  cytokinetics inc cytk today announced that data relating to patient baseline characteristics and the reasons for patient screen failure both from the first cohort of the phase  clinical trial of ck in spinal muscular atrophy were presented at the cure sma  annual sma conference in orlando fl by stacy rudnicki md director clinical research at cytokinetics briefcytokinetics says ching jaw joined co as senior vice president cfo on june   reuters –  pm et  cytokinetics inc cytk  cytokinetics inc cytk says ching jaw joined cytokinetics cytk as senior vice president chief financial officer on june    sec filing source text further company coverage briefcytokinetics starts phase b clinical trial of ck in elderly subjects reuters –  am et  cytokinetics inc cytk  cytokinetics cytk announces start of phase b clinical trial of ck in elderly subjects with limited mobility  cytokinetics inc cytk  clinical trial is expected to enroll at least  subjects in united states who are  to  years of age with limited mobility source text for eikon further company coverage cytokinetics announces start of phase b clinical trial of ck in elderly subjects with limited mobility globenewswire –  am et  cytokinetics incorporated cytk today announced the start of a phase b doubleblind randomized placebocontrolled multiple dose twoperiod crossover study to assess the effect of ck on measures of physical function in elderly adults with limited mobility daily technical summary reports on biotech stocks  concordia cytokinetics dermira and endocyte pr newswire –  am et  new york june   if you want a stock review on cxrx cytk derm or ecyt then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister concordia international  on monday shares in oakville canada headquartered concordia international corp cxrx recorded a trading volume of  shares cytokinetics announces presentations at the cure sma  annual sma conference globenewswire –  pm et  cytokinetics incorporated cytk today announced presentations at the cure sma  annual sma conference from june   july   in orlando fl in an oral presentation on july  stacy rudnicki md director clinical research and development at cytokinetics cytk will present data relating to patient baseline characteristics and the reasons for patient screen failure from the first cohort of the p cytokinetics to participate in panel on neuromuscular disorders at the jmp securities life sciences conference globenewswire –  pm et  cytokinetics inc cytk today announced that robert i blum president and chief executive officer is scheduled to participate in a panel discussion on neuromuscular disorders at the jmp securities  life sciences conference on june   at  pm edt at the st regis hotel in new york briefcytokinetics announces orphan drug designation for ck for treatment of spinal muscular atrophy reuters –  am et  cytokinetics inc cytk  cytokinetics cytk announces orphan drug designation for ck for the treatment of spinal muscular atrophy  expects to see results from its ongoing phase  clinical trial for ck later this year source text for eikon further company coverage cytokinetics announces orphan drug designation for ck for the treatment of spinal muscular atrophy globenewswire –  am et  cytokinetics incorporated cytk today announced that the office of orphan products development of the us food and drug administration has granted orphan drug designation to ck for the potential treatment of spinal muscular atrophy cytokinetics to hold annual meeting of stockholders globenewswire –  pm et  cytokinetics incorporated cytk today announced that its annual meeting of stockholders will be held on thursday may   at  am pacific time at the embassy suites hotel located at  gateway boulevard in south san francisco ca robert i blum president and chief executive officer is scheduled to present an overview of cytokinetics performance briefcytokinetics prices  mln common shares at  per share reuters –  pm et  cytokinetics inc cytk  cytokinetics cytk announces pricing of public offering of common stock  says public offering of  million common shares priced at per share source text for eikon further company coverage cytokinetics announces pricing of public offering of common stock globenewswire –  pm et  cytokinetics incorporated cytk today announced the pricing of an underwritten public offering of  shares of its common stock at a price to the public of  per share before underwriting discounts and commissions morgan stanley is acting as sole underwriter for the offering briefcytokinetics announces proposed public offering of common stock reuters –  pm et  cytokinetics inc cytk  cytokinetics cytk announces proposed public offering of common stock  cytokinetics inc cytk says  million of its common stock in an underwritten public offering source text for eikon further company coverage cytokinetics announces proposed public offering of common stock globenewswire –  pm et  cytokinetics incorporated cytk today announced plans to offer subject to market and other conditions  of its common stock in an underwritten public offering morgan stanley is acting as sole underwriter for the offering cytokinetics and the als association renew partnership to advance the fight against als globenewswire –  pm et  south san francisco calif and washington may    cytokinetics inc cytk and the als association today announced the continuation of their partnership in the fight against als which includes cytokinetics renewal of its gold level sponsorship of the national walks to defeat als® and premier level national als advocacy conference sponsorship as well as platinum level sponsorship for initi briefcytokinetics announces results from dose escalation phase of cosmichf reuters –  am et  cytokinetics inc cytk  cytokinetics cytk announces results from dose escalation phase of cosmichf  dose escalation phase of cosmichf supported selection of optimal formulation of omecamtiv mecarbil source text for eikon further company coverage cytokinetics announces results from dose escalation phase of cosmichf presented at heart failure  globenewswire –  am et  cytokinetics inc cytk today announced that results from the dose escalation phase of cosmichf a phase  trial evaluating omecamtiv mecarbil in patients with chronic heart failure were presented at heart failure  the annual congress of the heart failure association of the european society of cardiology held in paris april may   briefcytokinetics q loss per share  reuters –  pm et  cytokinetics inc cytk  cytokinetics inc reports first quarter  financial results  q revenue  million versus  million  q loss per share   q earnings per share view  revenue view  million  thomson reuters ibes source text for eikon further company coverage cytokinetics inc reports first quarter  financial results globenewswire –  pm et  data monitoring committee for vitalityals recommended continuation of phase  trial results expected in q sale of royalty on omecamtiv mecarbil to royalty pharma contributed to increased cash balance expansion of clinical trials program for ck in collaboration with astellas south san francisco calif april    cytokinetics inc cytk reported total revenues for the first quart page page   next  todays and upcoming events aug  cytk to announce q earnings after market confirmed past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe wendell wierenga  patara pharma bod wendell wierenga dr wierenga has over  years of pharmaceutical drug discovery and development experience in a wide range of therapeutic areas as well as extensive board experience at private and public biotech companies dr wierenga previously served as evp research and development at santarus ambit biosciences and neurocrine biosciences he also served as ceo of syrrx now part of takeda pharmaceutical company svp of worldwide pharmaceutical sciences technologies and development at parkedaviswarner lambert now pfizer inc and held various research and discovery roles at upjohn pharmaceuticals most recently as executive director of discovery research during his career he has directed over  inds  ndas involving small molecules and biologics that have lead to  marketed products including lipitor neurontin and uceris dr wierenga was formally on the board of onyx pharmaceuticals before its sale to amgen for  billion and currently serves on the boards of cytokinetics cytk ocera therapeutics ocrx concert pharmaceuticals cnce apricus biosciences apri and anacor pharmaceuticals anac he has over  publications and presentations and has been awarded over  patents dr wierenga holds a ba from hope college and a phd in chemistry from stanford university menu home disease product about news contact wendall wayne wierenga  battle creek mi  intelius sign in we found wendall wayne wierenga in battle creek mi wendall wayne wierenga intelius found that wendall wayne wierenga is between  and  years old from battle creek mi we have connected them to  addresses  phone and  relative or associate get report now age wendall wayne wierenga is in his s wendall has lived in battle creek mi south san francisco ca coeur d alene id wendalls relatives windy wierenga wendall wayne wierenga zodiac signsagittarius professional status director at cytokinetics  incorporated get report now want to know more about wendall get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about wendall or use our people search engine to find others get background check on wendall wayne wierenga get a criminal check on wendall wayne wierenga get a public record report on wendall wayne wierenga get a people search report on wendall wayne wierenga wendall wayne wierengas contact information known cities lived in find out where wendall wayne wierenga has lived as well as wendall wayne wierengas phone numbers and email addresses wendall wayne wierenga has lived in  states michigan address for wendall wayne wierenga  h s battle creek mi has lived in battle creek mi south san francisco ca get full address report phone numbers associated with wendall wayne wierenga    battle creek mi get full phone report email addresses associated with wendall wayne wierenga get email report wendall wayne wierengas professional information information regarding wendall wayne wierengas professional history find out previous places wendall wayne wierenga has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act wendall wayne wierenga has worked at  place company cytokinetics  incorporated title director wendall wayne wierengas experience title director company cytokinetics  incorporated job details cytokinetics is a latestage biopharmaceutical company focused on discovering developing and commercializing firstinclass muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised andor declining as a leader in muscle biology and the mechanics of muscle performance the company is developing small molecule drug candidates specifically engineered to increase muscle function and contractility cytokinetics lead drug candidate is tirasemtiv a fast skeletal muscle activator for the potential treatment of als tirasemtiv has been granted orphan drug designation and fast track status by the us food and drug administration and orphan medicinal product designation by the european medicines agency for the potential treatment of als cytokinetics holds the exclusive right to develop and commercialize tirasemtiv throughout the world cytokinetics is collaborating with amgen inc to develop omecamtiv mecarbil a novel cardiac muscle activator for the potential treatment of heart failure cytokinetics is collaborating with astellas pharma inc to develop ck a fast skeletal muscle activator for the potential treatment of spinal muscular atrophy amgen holds an exclusive license worldwide to develop and commercialize omecamtiv mecarbil and astellas holds an exclusive license worldwide to develop and commercialize ck both licenses are subject to cytokinetics specified development and commercialization participation rights additional professional information on wendall wayne wierenga see wendall wayne wierengas linkedin profile wendall wayne wierengas social network and potential email matches find out potential social network profiles and potential email usernamed for wendall wayne wierenga wendall wayne wierengas known social networks and potential email matches find all of wendall wayne wierengas social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches wendall wierenga username matches wendallwierenga wierengawendall wendallwierenga wierengawendall wendallwierenga wierengawendall wendallwierenga wierengawendall wwierenga popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches w wierenga intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here dermata therapeutics llc announced the addition of wendell wierenga phd to its board of dermata therapeutics llc announced the addition of wendell wierenga phd to its board of directors news provided by dermata therapeutics llc sep    et share this article san diego sept   prnewswire  dermata therapeutics llc a biotechnology company developing innovative medical dermatology products for dermatologists and their patients today announced the appointment of wendell wierenga phd to its board of directors dr wierenga joins dermatas board of directors with broad rd experience in all therapeutic categories in both small and large companies extensive board and leadership experience and a diverse functional background in chemistry biology medicine analytical science and formulation sciences over the course of his career he has been involved in over  inds  ndas  marketed products and been awarded  patents we are very excited to have wendell be part of our board of directors i have worked with wendell for many years and believe he will be an invaluable asset in helping with the development of our programs from his years of experience in biotech said gerry proehl president ceo and director of dermata in his most recent position dr wierenga served as executive vice president research and development at santarus inc a specialty biopharmaceutical company in san diego ca that was acquired by salix pharmaceuticals in january  for  billion prior to joining santarus he held the position of executive vice president research and development at both ambit biosciences and neurocrine biosciences before joining neurocrine dr wierenga served as ceo of syrrx inc a private biotech company who was acquired by takeda pharmaceuticals in  dr wierenga earned his phd in chemistry from stanford university and his ba from hope college in holland michigan he is currently a member of the board of directors of cytokinetics ocera therapeutics and sri intl and most recently was on the board of directors for anacor pharmaceuticals and xenoport inc prior to their sales to pfizer and arbor pharmaceuticals respectively he is also a member of the scientific advisory board for concert pharmaceuticals ferring pharmaceuticals and atyr pharma inc about dermata dermata is a developmentstage biotechnology company focused on making major advancements in the treatment of serious diseases treated by dermatologists dermata has a team of experienced individuals who are currently focused on progressing four programs for the treatment of acne rosacea acne vulgaris atopic dermatitis and ocular rosacea to learn more about dermata and its pipeline of treatments please visit wwwdermatarxcom contact dermata contact gerald proehl president and ceo  gproehldermatarxcom   logo  httpphotosprnewswirecomprnhlogo   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesdermatatherapeuticsllcannouncedtheadditionofwendellwierengaphdtoitsboardofdirectorshtml source dermata therapeutics llc related links httpwwwdermatarxcom sep    et preview dermata therapeutics llc announces positive topline results from their phase  pharmacokinetic study of dmt in acne rosacea patients may    et preview dermata therapeutics llc announces initiation of phase  pharmacokinetic study my news release contains wide tables view fullscreen also from this source apr    et dermata therapeutics llc and villani inc announce a global feb    et dermata therapeutics llc closes a  million series a financing explore more news releases in similar topics biotechnology health care  hospitals personnel announcements you just read dermata therapeutics llc announced the addition of wendell wierenga phd to its board of directors news provided by dermata therapeutics llc sep    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search anacor pharmaceuticals appoints wendell wierenga to its board of directors  pg  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street anacor pharmaceuticals appoints wendell wierenga to its board of directors business wire sep    am edt “i am very pleased to become a member of the anacor board” said wendell wierenga “anacor recently achieved a significant milestone with fda’s approval of kerydin tm and i look forward to contributing to the continued success of the company” about anacor pharmaceuticals anacor is a biopharmaceutical company focused on discovering developing and commercializing novel smallmolecule therapeutics derived from its boron chemistry platform anacor’s first approved drug kerydin tm tavaborole topical solution  is an oxaborole antifungal approved by the us food and drug administration in july  for the topical treatment of onychomycosis of the toenails in july  anacor entered into an exclusive agreement with sandoz inc a novartis company pursuant to which sandoz will distribute and commercialize kerydin in the united states anacor’s lead product candidate is an an investigational antiinflammatory pde inhibitor in development for the potential treatment of mildtomoderate atopic dermatitis and psoriasis beyond kerydin and an anacor has discovered synthesized and is developing six molecules these include three whollyowned investigational product candidates an is an investigational topical antifungal an is a backup compound to an and an is an investigational antibiotic for the potential treatment of infections caused by gramnegative bacteria anacor has also discovered three other investigational compounds that it has outlicensed for further development the first compound is licensed to eli lilly and company for the potential treatment of an animal health indication the second compound an is licensed to drugs for neglected diseases initiative for the potential treatment of human african trypanosomiasis hat or sleeping sickness and the third compound is licensed to glaxosmithkline llc for development in tuberculosis anacor also has a pipeline of other internally discovered topical and systemic boronbased compounds in earlier stages of research and preclinical development for more information visit httpwwwanacorcom forwardlooking statements this press release contains forwardlooking statements including statements regarding the progress timing and results of anacor’s clinical trials safety and efficacy of anacor’s product candidates timing and potential approval of anacor’s product candidates and timing and potential commercial success of anacor’s products these statements constitute forwardlooking statements within the meaning of section a of the securities act of  and section e of the securities exchange act of  the words “may” “might” “will” “should” “estimate” “project” “plan” “anticipate” “expect” “intend” “outlook” “believe” and other similar expressions are intended to identify forward looking statements readers are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date of this release and anacor undertakes no obligation to update any forwardlooking statement in this press release except as required by law these forward looking statements are based on estimates and assumptions by anacor’s management that although believed to be reasonable are inherently uncertain and subject to a number of risks and uncertainties the following represent some but not necessarily all of the factors that could cause actual results to differ from historical results or those anticipated or predicted by anacor’s forwardlooking statements the timely and successful launch of kerydin pursuant to anacor’s distribution and commercialization agreement with sandoz any issues or delays arising during the course of anacor’s phase  studies or other studies relating to an any delay or failure by the fda to approve an anacor’s ability to timely and successfully launch either alone or with a partner an and the other risks identified in anacor’s periodic filings including anacor’s quarterly report on form q for the quarter ended june   if you liked this article you might like lack of catalysts keeps analysts away from pfizer pfizer may not be the best investment in coming months as doubts surface about the companys nearterm prospects in the absence of ma alicia mcelhaney oct    pm edt read scraps pfizer breakup as megadeals escape its grasp the company has spent  million weighing a potential breakup sarah pringle sep    pm edt allergans dealmaking continues with vitae takeout the  million deal marks the the third purchase for brent saunders since early august sarah pringle sep    pm edt will pfizer book another healthy quarter pfizer shares are up  year to date and the company reports earnings on aug  heres what to expect chris laudani jul    am edt trending trump just resurrected the ugly practice known as civil forfeiture for no reason  reasons dying sears had to strike a deal with the ruthless amazon ftc seen as set to block rite aid deal starbucks has an alarming problem that even its fans must admit has to be fixed  and soon gm may slash six car models to combat slumping sales avoid plant layoffs advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers wendall wierenga  cytokinetics inc  zoominfocom microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft amazoncom wierenga interesting finds updated daily amazon try prime all all departments alexa skills amazon devices amazon video amazon warehouse deals appliances apps  games arts crafts  sewing automotive parts  accessories baby beauty  personal care books cds  vinyl cell phones  accessories clothing shoes  jewelry    women    men    girls    boys    baby collectibles  fine art computers courses credit and payment cards digital music electronics gift cards grocery  gourmet food handmade health household  baby care home  business services home  kitchen industrial  scientific kindle store luggage  travel gear luxury beauty magazine subscriptions movies  tv musical instruments office products patio lawn  garden pet supplies prime exclusive prime pantry software sports  outdoors tools  home improvement toys  games vehicles video games wine go departments en   hello sign inaccount  listssign inaccount  listsorderstry primecart your amazoncomtodays dealsgift cards  registrysellhelpdisability customer support  of  results for wierenga sort by  relevance price low to high price high to low avg customer review newest arrivals the philosophy of religion first books in philosophyaug  by edward r wierengapaperback    primefree shipping on eligible ordersonly  left in stock  order soonmore buying choices used amp new offershardcover    primefree shipping on eligible ordersonly  left in stock  order soonmore buying choices used amp new offers  out of  stars sandcastles made simple stepbystep instructions tips and tricks for building sensational sand creationsmay  by lucinda wierengapaperback    primeget it by tuesday jul free shipping on eligible ordersmore buying choices used amp new offershardcover used amp new offers  out of  stars making it home finding my way to peace identity and purposesep  by emily t wierengapaperback    primeget it by today jul free shipping on eligible ordersmore buying choices used amp new offerskindle edition     out of  stars a promise in pieces quilts of love seriesapr  by emily t wierengapaperback    primeget it by tuesday jul free shipping on eligible ordersmore buying choices used amp new offerskindle edition    other formatsaudible audio edition mp cd  out of  stars book  of  in the quilts of love series wierenga premium beer  ale coasters  set of by j edgar cool      shippingub wierenga family name bar  grill home decor neon light signby advpro name      shippingonly  left in stock  order soon printed wierenga oval euro style magnet for any metal surfaceby beach graphic pros      shippingrustic wierenga family bar  grill handmade wooden lastname sign   x  inchesby the lizton sign shop      shippingproduct description rustic wierenga family bar  grill handmade wooden lastname sign   the nature of god an inquiry into divine attributes cornell studies in the philosophy of religionmar  by edward r wierengapaperback    primefree shipping on eligible ordersonly  left in stock  order soonmore buying choices used amp new offershardcover used amp new offers  out of  stars if you were me an lived in cuba a childs introduction to cultures around the worldjul  by carole p roman and kelsea wierengakindle editionread this and over  million books withkindle unlimited    to buypaperback    primefree shipping on eligible ordersin stockother formatshardcover  out of  stars borrow for free from your kindle devicejoin amazon primeeverything we already knewnov  by hannah rose graves  justin wierengamp music    available for download nowwierengas craft beer stretched canvas sign   x by j edgar cool      shippingrespect in youjan  by the respect sextetaudio cd    primefree shipping on eligible ordersonly  left in stock  order soonmore buying choices used amp new offers  out of  stars wierenga family name beer and ale rubber drink coasters  set of by zuwee      shippingonly  left in stock  order soon printed wierenga oval euro style vinyl decal stickerby beach graphic pros      shippingif you were me and lived inegypt a childs introduction to cultures around the world volume feb  by carole p roman and kelsea wierengapaperback    primeget it by tuesday jul free shipping on eligible ordersmore buying choices used amp new offerskindle editionread this and over  million books withkindle unlimited    to buyother formatshardcover  out of  stars  previous page      next page sponsored links whats this ad feedback search feedbackdid you find what you were looking foryesno choose a category that best describes the issue that you are having with the searchchoose a category…i need to talk to customer servicei still havent found what im looking forhow do i filter or sort my search something is brokena picture or description looks wrongcould you add a feature could you start carrying a product not listed here choose a category… leave us some comments about your search your comments can help make our site better for everyonesubmit get express customer service or contact us by email or phonecontact us thank you for your feedback if you need help or have a question for customer service please visit the help section show results forkindle storechildrens ebookschildrens explore europe booksbookseating disorder selfhelpwomens biographieschildrens europe booksreligious literature  fictionchristian literature  fictionmarket research businesshomeschoolingdigital musiceverything elsehome  kitchenautomotive parts  accessoriescds  vinyltools  home improvementsee all  departmentsrefine bydelivery dayget it todayget it by tomorrowamazon primeeligible for free shippingfree shipping by amazonbook seriesquilts of lovebrio girlskindle unlimitedkindle unlimited eligiblebook languageenglishbook formatkindle editionhardcoverpaperbackchildrens books age rangebabyages ages ages avg customer review stars  up  up stars  up  up stars  up  up star  up  upinternational shippingamazonglobal eligibleconditionnewused theres a problem loading this menu right now learn more about amazon prime get fast free shipping with amazon prime prime members enjoy free twoday shipping and exclusive access to music movies tv shows original audio series and kindle books  get started your recently viewed items and featured recommendations › view or edit your browsing history after viewing product detail pages look here to find an easy way to navigate back to pages you are interested in your recently viewed items and featured recommendations › view or edit your browsing history after viewing product detail pages look here to find an easy way to navigate back to pages you are interested in back to top get to know uscareersabout amazoninvestor relationsamazon devicesmake money with ussell on amazonsell your services on amazonsell on amazon businesssell your apps on amazonbecome an affiliateadvertise your productsselfpublish with usbecome an amazon vendorsell your subscription on amazon›see allamazon payment productsamazon rewards visa signature cardsamazoncom store cardamazoncom corporate credit lineshop with pointscredit card marketplacereload your balanceamazon currency converterlet us help youyour accountyour ordersshipping rates  policiesamazon primereturns  replacementsmanage your content and devicesamazon assistanthelp english united states amazon music stream millions of songs amazon drive cloud storage from amazon pm score deals on fashion brands abebooks books art  collectibles acx audiobook publishing made easy alexa actionable analytics for the web amazon business everything for your business   amazonfresh groceries  more right to your door amazonglobal ship orders internationally home services handpicked pros happiness guarantee amazon inspire digital educational resources amazon rapids fun stories for kids on the go amazon restaurants food delivery from local restaurants amazon video direct video distribution made easy   amazon web services scalable cloud computing services audible download audio books audiobookstand discount audiobooks on disc book depository books with free delivery worldwide box office mojo find movie box office data comixology thousands of digital comics createspace indie print publishing made easy   dpreview digital photography east dane designer mens fashion fabric sewing quilting  knitting goodreads book reviews  recommendations imdb movies tv  celebrities imdbpro get info entertainment professionals need jungleecom shop online in india   kindle direct publishing indie digital publishing made easy prime now free hour delivery on everyday items prime photos unlimited photo storage free with prime shopbop designer fashion brands tenmarkscom math activities for kids  schools warehouse deals openbox discounts whispercast discover  distribute digital content     withoutabox submit to film festivals woot deals and shenanigans zappos shoes  clothing souqcom shop online in the middle east subscribe with amazon discover  try subscription services   conditions of useprivacy noticeinterestbased ads  amazoncom inc or its affiliates robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates amazoncom amazon music unlimited interesting finds updated daily amazon try prime digital music all departments alexa skills amazon devices amazon video amazon warehouse deals appliances apps  games arts crafts  sewing automotive parts  accessories baby beauty  personal care books cds  vinyl cell phones  accessories clothing shoes  jewelry    women    men    girls    boys    baby collectibles  fine art computers courses credit and payment cards digital music electronics gift cards grocery  gourmet food handmade health household  baby care home  business services home  kitchen industrial  scientific kindle store luggage  travel gear luxury beauty magazine subscriptions movies  tv musical instruments office products patio lawn  garden pet supplies prime exclusive prime pantry software sports  outdoors tools  home improvement toys  games vehicles video games wine go departments en   hello sign inaccount  listssign inaccount  listsorderstry primecart your amazoncomtodays dealsgift cards  registrysellhelpdisability customer support amazon music unlimited prime music cds  vinyl download store open web player mp cart settings mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial theres a problem loading this menu right now learn more about amazon prime get fast free shipping with amazon prime prime members enjoy free twoday shipping and exclusive access to music movies tv shows original audio series and kindle books  get started v